Skip to main content

New antiviral drug from Merck could help reduce COVID hospitalizations and deaths

Pharmaceutical giant Merck announced promising results from a study of a new antiviral drug. Molnupiravir reduced COVID hospitalizations or death by 50% in a trial involving 775 volunteers.

[Copyright 2021 NPR]

Why you can trust KUOW
Close
On Air Shows

Print

Print

Play Audio
 Live Now On KUOW
KUOW Live Stream
On Air Shows

Print

Print

Play Audio
Local Newscast
The Latest
View All
    Play Audio